{"id":48105,"date":"2022-09-08T14:01:52","date_gmt":"2022-09-08T12:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/"},"modified":"2022-09-08T14:01:52","modified_gmt":"2022-09-08T12:01:52","slug":"lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/","title":{"rendered":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development"},"content":{"rendered":"
\n

LAUSANNE, Switzerland & TEL AVIV, Israel–(BUSINESS WIRE)–#biomarker<\/a>—Lunaphore<\/a>, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai<\/a>, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cWe are thrilled to announce the partnership with Lunaphore and combine Lunaphore\u2019s best-in-class flagship COMET\u2122, a hyperplex staining and imaging platform, with Nucleai\u2019s ATOM platform that uniquely supports multiplex, IHC, and H&E data,\u201d said Avi Veidman, Chief Executive Officer of Nucleai. \u201cThis strategic partnership will allow us to utilize multiplex technology and provide a complete, actionable, and scalable solution to improve drug target discovery and development of our pharma and biotech partners.\u201d\n<\/p>\n

\nMapping biological microenvironments with spatial mapping technology is an exciting area of discovery. Lunaphore\u2019s novel COMET\u2122<\/a> technology unlocks the power of immunofluorescence spatial biology with a robust and user-friendly system, permitting the use of any non-conjugated antibodies and enabling the wide adoption of spatial biology in laboratories. Nucleai has built a platform that makes spatial analysis scalable and operational, enabling the next generation of actionable insights from massive pathology data sets that have not been analyzed to their fullest potential and could provide significant value to pharmaceutical companies and diagnostic labs.\n<\/p>\n

\nThe partnership will utilize Lunaphore\u2019s innovative COMET\u2122 platform for hyperplex staining and imaging with Nucleai\u2019s cutting-edge AI spatial models to derive new insights from tissue biopsies, including novel drug targets, mechanisms of action, and biomarkers to advance the field of precision medicine. The combined solutions will provide laboratories with an integrated end-to-end spatial biology workflow from automated, hyperplex sequential immunofluorescence staining and imaging to AI-enabled, state-of-the-art image processing, and data analytics. As part of the partnership, the companies also plan to develop predictive and prognostic spatial biomarker assays.\n<\/p>\n

\n\u201cOur partnership with Nucleai is based on our shared vision to advance next-generation spatial multiplex immunofluorescence imaging to accelerate drug and biomarker discovery and development,\u201d said D\u00e9borah Heintze, Chief Marketing Officer of Lunaphore. \u201cConnecting Nucleai\u2019s solution with COMET\u2122, we have the potential to more precisely characterize the immune system and disease microenvironment to provide deeper biological insights to drug developers.\u201d\n<\/p>\n

\n\u201cNucleai brings innovative spatial biology and machine learning platform (ATOM) to empower researchers with novel insights into drug discovery,\u201d said Mridula Iyer, Ph.D., Vice President of Strategic Partnerships at Nucleai. \u201cThe technology is designed to unlock and analyze valuable data from pathology slides previously inaccessible, leading to the development of new precise targeted therapy that is important for patient outcomes. This collaboration is another example of how both Lunaphore and Nucleai are accelerating efforts to partner with pharmaceutical and biopharmaceutical companies, as well as medical research institutions and other biomedical organizations.\u201d\n<\/p>\n

\nAbout COMET\u2122<\/b>\n<\/p>\n

\nCOMET\u2122 is a fully automated sequential immunofluorescence (seqIF\u2122) instrument, able to perform hyperplex staining and imaging, producing high-quality data in a robust and reproducible manner. With superior tissue profiling capabilities, the system allows multiplex analysis of up to 40 different spatial markers per tissue slide without human intervention. COMET\u2122 has a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology in areas such as immuno-oncology, neuroscience, and infectious diseases. The technology has the ability to revolutionize clinical applications such as drug discovery and biomarker development. To learn more about the COMET\u2122 platform, please visit: https:\/\/lunaphore.com\/products\/comet\/<\/a>.\n<\/p>\n

\nAbout Lunaphore<\/b>\n<\/p>\n

\nLunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore has developed a game-changing chip technology that can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Lunaphore empowers researchers to push the boundaries of research to ultimately develop the next generation personalized therapies. For further information on Lunaphore and its products, please visit www.lunaphore.com<\/a>.\n<\/p>\n

\nAbout Nucleai<\/b>\n<\/p>\n

\nNucleai is an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking the power of pathology data. Nucleai provides pharmaceutical companies, Contract Research Organizations, and diagnostics laboratories with a state-of-the-art AI platform to improve clinical trials and clinical decision-making. For more information, please visit www.nucleai.ai<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLunaphore:<\/b>
Irene Tamayo<\/b>
Lunaphore Corporate Communications
\n
Email: communications@lunaphore.com<\/a>\n<\/p>\n

\nNucleai:<\/b>
Mridula Iyer<\/b>
VP, Strategic Partnerships
\n
Email: mridula.iyer@nucleai.ai<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LAUSANNE, Switzerland & TEL AVIV, Israel–(BUSINESS WIRE)–#biomarker—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48105","6":"format-standard","7":"category-industry"},"yoast_head":"\nLunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LAUSANNE, Switzerland & TEL AVIV, Israel–(BUSINESS WIRE)–#biomarker—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T12:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development\",\"datePublished\":\"2022-09-08T12:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/\"},\"wordCount\":759,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005132\\\/en\\\/1564297\\\/21\\\/Nuclei_PR_FS_lung.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/\",\"name\":\"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005132\\\/en\\\/1564297\\\/21\\\/Nuclei_PR_FS_lung.jpg\",\"datePublished\":\"2022-09-08T12:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005132\\\/en\\\/1564297\\\/21\\\/Nuclei_PR_FS_lung.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005132\\\/en\\\/1564297\\\/21\\\/Nuclei_PR_FS_lung.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend","og_description":"LAUSANNE, Switzerland & TEL AVIV, Israel–(BUSINESS WIRE)–#biomarker—Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T12:01:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development","datePublished":"2022-09-08T12:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/"},"wordCount":759,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/","url":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/","name":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg","datePublished":"2022-09-08T12:01:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005132\/en\/1564297\/21\/Nuclei_PR_FS_lung.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48105"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48105\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}